The registration, importation and distribution of all heartburn medication containing ranitidine has been suspended in the UAE.
According to the Ministry of Health and Prevention (MoHAP), a circular was issued to health facilities and practitioners informing them about the move.
The decision is based on the recommendations of the US Food and Drug Administration (FDA) and other regulatory bodies regarding a possible contamination of the medicine with an impurity which is classified as potentially carcinogenic.
The Ministry says those wishing to stop taking medicine with ranitidine should consult a healthcare professional for a replacement.
H.H. Sheikh Hamdan announces contactless hotel check-in rollout
UAE to change Friday prayer timing from January
UNESCO hosts high-level talks on ‘information integrity’ at BRIDGE Summit
Fire breaks out at Al Reem Island construction site
Sri Lankan Army praises UAE search and rescue team
UAE announces $550 million for UN’s 2026 Global Humanitarian Overview
Over 3.5 million interactions on BRIDGE Summit's App on opening day
Dubai launches system to expedite funeral procedures
